Vietnam records another community COVID-19 infection case
Vietnam reported another COVID-19 infection in the community, and detected no imported cases within the past 12 hours as of 6am on February 2, according to the National Steering Committee for COVID-19 Prevention and Control.
Vietnam has developed COVID-19 vaccine since last year. (Photo: VNA)
Hanoi (VNA) - Vietnam reported another COVID-19 infection in the community, anddetected no imported cases within the past 12 hours as of 6am on February 2,according to the National Steering Committee for COVID-19 Prevention andControl.
The latest case, Patient 1,851, is a 44-year-old man who lived in Lai Cachtown, Cam Giang district, the northern province of Hai Duong.
He testedpositive with the SARS-CoV-2 on February 1 after having symptoms of fever,coughing and sore throat and getting medical examination at Hai Duong General Hospitalon January 31.
The patient is under treatment at the hospital. Competent authorities are examining his travel history.
The country has recorded 1,851 SARS-CoV-2 infections so far. Of the total, 964 were locally-transmitted cases, including 271 linked with Hai Duong since thelatest coronavirus outbreak hit the province on January 27.
According to a report from the Treatment Sub-committee under National SteeringCommittee for COVID-19 Prevention and Control, 1,460 COVID-19 patients haverecovered.
Among the patients still under treatment, eight have tested negativefor the virus one, five twice, and three thrice. Thirty five died fromcomplications related to the disease.
There are 27,714 people who had close contact with confirmed cases or comingfrom the pandemic-hit regions under quarantine at present, including 227 athospitals, 20,917 in other quarantine sites, and 6,570 at home./.
Deputy Minister of Health Truong Quoc Cuong on February 1 signed a decision approving the use of the AstraZeneca COVID-19 vaccine due to the urgent need for prevention and control of the pandemic.
Thousands of volunteers are working online to help quickly verify information on F1, F2, and F3 cases linked to COVID-19 infections, heard a meeting in Hanoi on February 1 reviewing the work of the COVID-19 quick information response team.
French pharmaceutical company Sanofi Vietnam was among seven companies to receive a certificate of merit from the Minister of Health for contributions to COVID-19 prevention in Vietnam.
Vietnam recorded 31 new COVID-19 infections, including one imported case, over the last 12 hours from 6am on February 1, according to the National Steering Committee on COVID-19 Prevention and Control.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.